OCCURRENCE OF PRODUCTS OF PROGASTRIN-RELEASING PEPTIDE IN HUMAN TUMORS

被引：0
|
作者：
BJORNSKOVBARTHOLDY, L [1 ]
JUVIC, J [1 ]
SCOPSI, L [1 ]
HOLST, JJ [1 ]
机构：
[1] UNIV COPENHAGEN,PANUM INST,DEPT MED PHYSIOL C,DK-2200 COPENHAGEN,DENMARK
来源：
REGULATORY PEPTIDES | 1992年 / 40卷 / 02期
关键词：
D O I：
10.1016/0167-0115(92)90144-J
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：113 / 113
页数：1
相关论文
共 50 条
  • [31] Detection of micro dissemination of cancer cells by testing for progastrin-releasing peptide expression in the peripheral blood of SCLC patients
    Kimura, Hideharu
    Kasahara, Kazuo
    CANCER RESEARCH, 2009, 69
  • [32] Elevated serum progastrin-releasing peptide (31-98) in metastatic and androgen-independent prostate cancer patients
    Yashi, M
    Muraishi, O
    Kobayashi, Y
    Tokue, A
    Nanjo, H
    PROSTATE, 2002, 51 (02): : 84 - 97
  • [33] Elevated progastrin-releasing peptide(31-98) concentrations in pleural effusions due to small-cell lung carcinoma
    Shijubo, N
    Hirasawa, M
    Sasaki, H
    Igarashi, T
    Fujita, A
    Kodama, T
    Yamaguchi, K
    Abe, S
    RESPIRATION, 1996, 63 (02) : 106 - 110
  • [34] Diagnostic and therapeutic value of progastrin-releasing peptide on small-cell lung cancer: A Single-Center Experience in China
    Wu, Xiao-Yuan
    Hu, Yang-Bo
    Li, Hui-Juan
    Wan, Bing
    Zhang, Chen-Xi
    Zhang, Bin
    Hu, Huan
    Zhang, Qun
    Lv, Tang-Feng
    Zhan, Ping
    Song, Yong
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2018, 22 (09) : 4328 - 4334
  • [35] Bioactive neuropeptide precursor, progastrin-releasing peptide (ProGRP) is a distinct prognostic marker in metastatic and hormone-refractory prostate cancer
    Yashi, M.
    Ikeda, M.
    Oguchi, T.
    Shiga, Y.
    Endo, F.
    Hattori, K.
    Muraishi, O.
    Yagisawa, T.
    EUROPEAN UROLOGY SUPPLEMENTS, 2008, 7 (03) : 207 - 207
  • [36] Aptamer based surface plasma resonance assay for direct detection of neuron specific enolase and progastrin-releasing peptide (31-98)
    Sun, Linlin
    Shen, Kemin
    Zhang, Jianbin
    Wan, Wenjuan
    Cao, Wenjun
    Wang, Zhijun
    Guo, Chongzheng
    RSC ADVANCES, 2021, 11 (51) : 32135 - 32142
  • [37] EXPRESSION OF AMIDATED AND NON-AMIDATED PEPTIDES DERIVED FROM PROGASTRIN-RELEASING PEPTIDE IN RENAL CANCERS, AND RENAL CANCER CELL LINES
    Ischia, Joseph
    Bolton, Damien M.
    Ischia, Liesl
    Patel, Oneel
    Lockie, Rachele
    Baldwin, Graham
    Schulkes, Arthur S.
    JOURNAL OF UROLOGY, 2009, 181 (04): : 112 - 112
  • [38] An elevated progastrin-releasing peptide level in patients with well-differentiated neuroendocrine tumours indicates a primary tumour in the lung and predicts a shorter survival
    Korse, C. M.
    Taal, B. G.
    Bonfrer, J. M. G.
    Vincent, A.
    van Velthuysen, M. L.
    Baas, P.
    ANNALS OF ONCOLOGY, 2011, 22 (12) : 2625 - 2630
  • [39] Choice of serum tumor markers in patients with small cell lung cancer: progastrin-releasing peptide, neuron-specific enolase, and carcinoembryonic antigen
    Huang LiSi
    Yan HaiYan
    Sun LongQiaoZi
    Xu Ying
    Cai DongHao
    Li XiaoHui
    Chen XinLiang
    Luo XiaoHong
    Duan ChaoHui
    生物组学研究杂志（英文）, 2018, 1 (01)
  • [40] Elevated serum progastrin-releasing peptide (31-98) level is a predictor of short response duration after hormonal therapy in metastatic prostate cancer
    Yashi, M
    Nukui, A
    Kurokawa, S
    Ochi, M
    Ishikawa, S
    Goto, K
    Kobayashi, Y
    Muraishi, O
    Tokue, A
    PROSTATE, 2003, 56 (04): : 305 - 312
12345